US2023383035A1PendingUtilityA1
Protein-polymer nanoassemblies and intracellular protein delivery
Est. expiryJul 19, 2039(~13 yrs left)· nominal 20-yr term from priority
C08F 220/281A61K 47/65A61K 47/60C08F 220/36C08F 220/283C08F 8/12C08F 2438/03
82
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides novel polymer-protein conjugates and molecular assemblies for controlled intracellular delivery of proteins, and compositions and methods of preparation and use thereof.
Claims
exact text as granted — not AI-modified1 - 20 . (canceled)
21 . A polymer-protein conjugate, comprising: a copolymer comprising a first monomer of PEG-methacrylate (PEG-MA) and a second monomer of methacrylate having a side chain conjugated to a protein via a degradable linker.
22 . The polymer-protein conjugate of claim 21 , wherein the degradable linker is sensitive to reactive oxygen species, a reducing environment, or change in pH.
23 . The polymer-protein conjugate of claim 22 , wherein the degradable linker comprises a boronate ester linker.
24 . The polymer-protein conjugate of claim 22 , wherein the degradable linker comprises a disulfide linker.
25 . The polymer-protein conjugate of claim 22 , wherein the degradable linker comprises a cis-aconityl linker.
26 . A molecular assembly comprising the polymer-protein conjugate of claim 21 .
27 . The molecular assembly of claim 26 , wherein the polymer:protein ratio by weight is in the range from about 1:1 to about 50:1.
28 . The molecular assembly of claim 26 , wherein the polymer-protein conjugate is adapted to release the protein for its native function upon degradation of the degradable linker.
29 . The molecular assembly of claim 28 , wherein the polymer-protein conjugate is adapted to release the protein in the presence of a specific and biologically relevant stimulus inside cells.
30 . The molecular assembly of claim 29 , wherein the polymer-protein conjugate is adapted to release the protein in the presence of a specific and biologically relevant stimulus in the cytosol.
31 . The molecular assembly of claim 27 , wherein the protein has a molecular weight in the range of about 10 kDa to about 500 kDa.
32 . The molecular assembly of claim 31 , wherein the protein has an isoelectric points (pI) in the range of about 3.0 to about 12.0.
33 . A composition comprising the molecular assembly of claim 26 .
34 - 54 . (canceled)Join the waitlist — get patent alerts
Track US2023383035A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.